Joel R. Cherry
Novo Nordisk
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Joel R. Cherry.
Nature Biotechnology | 1999
Joel R. Cherry; Michael Lamsa; Palle Schneider; Jesper Vind; Allan Svendsen; Aubrey Jones; Anders Hjelholt Pedersen
The Coprinus cinereus (CiP) heme peroxidase was subjected to multiple rounds of directed evolution in an effort to produce a mutant suitable for use as a dye-transfer inhibitor in laundry detergent. The wild-type peroxidase is rapidly inactivated under laundry conditions due to the high pH (10.5), high temperature (50°C), and high peroxide concentration (5–10 mM). Peroxidase mutants were initially generated using two parallel approaches: site-directed mutagenesis based on structure-function considerations, and error-prone PCR to create random mutations. Mutants were expressed in Saccharomyces cerevisiae and screened for improved stability by measuring residual activity after incubation under conditions mimicking those in a washing machine. Manually combining mutations from the site-directed and random approaches led to a mutant with 110 times the thermal stability and 2.8 times the oxidative stability of wild-type CiP. In the final two rounds, mutants were randomly recombined by using the efficient yeast homologous recombination system to shuffle point mutations among a large number of parents. This in vivo shuffling led to the most dramatic improvements in oxidative stability, yielding a mutant with 174 times the thermal stability and 100 times the oxidative stability of wild-type CiP.
Nature Biotechnology | 1999
Jon E. Ness; Mark Welch; Lori Giver; Manuel Bueno; Joel R. Cherry; Torben Vedel Borchert; Willem P. C. Stemmer; Jeremy Minshull
DNA family shuffling of 26 protease genes was used to create a library of chimeric proteases that was screened for four distinct enzymatic properties. Multiple clones were identified that were significantly improved over any of the parental enzymes for each individual property. Family shuffling, also known as molecular breeding, efficiently created all of the combinations of parental properties, producing a great diversity of property combinations in the progeny enzymes. Thus, molecular breeding, like classical breeding, is a powerful tool for recombining existing diversity to tailor biological systems for multiple functional parameters.
Current Opinion in Biotechnology | 2000
Joel R. Cherry
In the past year, a number of oxidative enzymes have been the target of directed evolution. Catalase reaction specificity has been shifted to peroxidase, the high pH, thermal and oxidative stability of a fungal peroxidase has been dramatically improved, and the substrate specificity of cytochrome P450 has been altered to include substrates that the wild-type enzymes are incapable of oxidizing.
Current Genetics | 2000
Susan L. Elrod; Aubrey Jones; Randy M. Berka; Joel R. Cherry
Abstract The hemA gene encoding 5-aminolevulinate synthase, the first enzyme in heme biosynthesis, was cloned from Aspergillus oryzae and evaluated as a selectable marker for the transformation of filamentous fungi. Deletion of the hemA gene resulted in a lethal phenotype that could be rescued either by the supplementation of culture media with 5-aminolevulinic acid (ALA) or by transformation with the wild-type hemA gene, but not by growth on rich media, nor by the addition of exogenous heme. Transformation of a hemA deletion strain with the hemA gene linked to a lipase expression cassette yielded ALA prototrophs expressing lipase. The hemA gene can therefore be used as a selectable marker for the transformation of A. oryzae.
Nature Biotechnology | 2016
Anu Acharya; Kate Bingham; Jay Bradner; Wylie Burke; R. Alta Charo; Joel R. Cherry; André Choulika; Tony Coles; Robert Cook-Deegan; Stanley T. Crooke; Emilia Díaz; Brent Erickson; L Val Giddings; Sebastian Giwa; Jim Greenwood; Vishal Gulati; Sam Hall; John Harris; Jamie Heywood; Colin Hill; Jeremy M Levin; Adina Mangubat; John Maraganore; Giovanni Mariggi; Barbara Jean Mazur; Amy L. McGuire; Nathalie Moll; Jonathan D. Moreno; Gail Naughton; Lita Nelsen
A selection of individuals from the biotech ecosystem give their views on the challenges facing the sector over the coming years.
Nature Biotechnology | 2016
Anu Acharya; Kate Bingham; Jay Bradner; Wylie Burke; R. Alta Charo; Joel R. Cherry; André Choulika; Tony Coles; Robert Cook-Deegan; Stanley T Crook; Emilia Díaz; Brent Erickson; L Val Giddings; Sebastian Giwa; Jim Greenwood; Vishal Gulati; Sam Hall; John Harris; Jamie Heywood; Colin Hill; Jeremy M Levin; Adina Mangubat; John Maraganore; Giovanni Mariggi; Barbara Jean Mazur; Amy L. McGuire; Nathalie Moll; Jonathan D. Moreno; Gail Naughton; Lita Nelsen
Nat. Biotechnol. 34, 276–283 (2016); published online 10 March 2016; corrected after print 31 March 2016 In the version of this article initially published, Stanley Crookes name was misspelled as “Crook” in the author list. The error has been corrected in the HTML and PDF versions of the article.
Archive | 1994
Anders Hjelholt Pedersen; Jesper Vind; Allan Svendsen; Joel R. Cherry; Michael Lamsa; Palle Schneider; Birger Rostgaard Jensen
Archive | 1998
Torben Vedel Borchert; Titus Kretzschmar; Joel R. Cherry; Jesper Vind
Protein Engineering | 2000
Lars Beier; Allan Svendsen; Carsten Andersen; Torben P. Frandsen; Torben Vedel Borchert; Joel R. Cherry
Archive | 1997
Susan L. Elrod; Joel R. Cherry